VISIT US

ADLM Annual Meeting 2024

July 28–August 1, 2024 | Chicago, IL, USA

In-Booth Demonstrations

Our Hemostasis, Acute Care, Autoimmunity, Transfusion and Transplant systems, reagents, data management solutions, and more, will be featured.

To schedule an instrument demonstration or a meeting with our representatives, please contact us. Click the button below and submit the form with your clinical area(s) of interest.

Booth #2813

  • July 30-31: 9:30 AM–5:00 PM CT
  • August 1: 9:30 AM–1:00 PM CT

schedule-demo

 

Industry Workshop

July 30, 2024 | 1:45–2:45 PM CT

Challenges of hemolysis and K+ management

Join this presentation with Dr. Alan Wu and Chris Farnsworth, moderated by Dr. Annie Winkler who will discuss the challenges of hemolysis and K+ management.

schedule-demo

 

Join us at ADLM 2024 to learn about our latest innovations.

 

Visit Us

Booth #2813

July 30-31 | 9:30 AM-5:00 PM CT
August 1 | 9:30 AM-12:00 PM CT

Our Hemostasis, Acute Care, Autoimmunity, Transfusion and Transplant systems, reagents, digital solutions, and more, will be featured.

Speak with your Werfen rep or complete the form on this page to request an in-booth demonstration.

 

Hemostasis

Virtual Reality Laboratory Experience

See 3D customized layouts of HemoCell® Specialized Lab Automation workcells for Hemostasis Labs of all sizes, shapes, and volumes.

Virtual-reality-image

AID Flag

Integrated Lab+ solution for Autoimmunity
Visit our booth to see how our comprehensive Autoimmune diagnostics solution can help advance your lab’s capabilities by optimizing efficiency and enhancing clinical decision-making.

Integrated lab-base

 

Sign up for Werfen events at ADLM

Acute Care

Attend Our Industry Workshop

Challenges in Pre-Analytical Error Detection: Impact of Hemolysis and Potential Solutions

July 30 | 1:45-2:45 PM CT

Exhibit Hall, Theater 1

What might you be missing in your point-of-care blood gas results?  This workshop will focus on the challenges in pre-analytical error detection, including hemolysis, its prevalence, and impact on potassium and clinical outcomes. Current strategies and a new technology to detect hemolysis to mitigate risk at the point of care will also be discussed.

Workshop Objectives

Describe impact of hemolysis on whole blood potassium results
Identify challenges in current practices to assess in vitro hemolysis
Evaluate a new technology to detect hemolysis at the point of care
alan-photo

Alan Wu, PhD

Professor, Laboratory Medicine, University of California, San Francisco
Co-Core Lab Director, Zuckerberg San Francisco General Hospital
Chief, Clinical Pharmacogenomics Laboratory


Farsnworthphoto

Christopher Farnsworth, PhD

Assoc. Professor, Department of Pathology and Immunology, Washington University School of Medicine
Medical Director Clinical Chemistry POCT, St. Louis, MO

Save your spot!

Hemostasis-product line
Acute Care - Product Line
Transfusion - Product Line
AID Data Wave Image
Transplant-product line

Powering patient care.

Our passion for innovation—and commitment to help healthcare providers enhance hospital efficiency and patient care around the world—drives us to set new standards in Specialized Diagnostics.

Learn more about our Specialized Diagnostics.

ADLM24 LP NA Rev 00 5.24